ViaCyte Receives Funding to Continue Phase 1 and 2 Clinical Trials for Beta Cell Replacement

stem cell treatments

ViaCyte, headquartered in San Diego, has received funding commitments to continue clinical trials on their beta cell replacement products (1). The products, PEC-Direct and PEC-Encap, contain stem cells that differentiate into pancreatic cells, including insulin-secreting beta cells, after implantation. Additionally, these cells are housed in a capsule that prevents rejection of the implanted cells. If [Read More]

Harvard Scientist’s Family Inspires Stem Cell Research

Douglas Melton was studying frog eggs at a laboratory in Harvard University when his 6-month-old son Sam was diagnosed with type 1 diabetes. Later, the Melton’s daughter Emma was diagnosed with the same condition. Melton dropped what he was doing and launched efforts to create insulin-producing pancreatic cells in the laboratory. In people with type [Read More]

New Research into Diabetic Foot Ulcers and Stem Cell Treatment

Researchers at Egypt’s Assiut University are studying the application of stem cell treatment for chronic diabetic foot ulcers. The interventional study, which is not yet open for enrollment, is an open-label single group assessment. Diabetic Foot Ulcers and Amputations It is estimated that approximately 15 percent of diabetics develop a foot ulcer at some point [Read More]

Can Stem Cell Therapy Help Nerve Damage from Diabetes?

One of the earliest signs and most common complications of diabetes is nerve damage. The high levels of sugar (glucose) in the blood can injure nerve fibers in any part of the body, but this damage most often occurs in the legs and feet. This serious complication of diabetes is known as diabetic peripheral neuropathy.

Stem Cell Therapy for People with Type 1 Diabetes

Type 1 diabetes is a rare form of diabetes, typically diagnosed during childhood or adolescence. Previously known as juvenile diabetes, it affects only 5 percent of the total number of people with diabetes. In people with type 1 diabetes, the islet beta cells in the pancreas do not produce a sufficient amount of insulin. Insulin [Read More]

Healing Diabetic Foot Ulcers May Become Easier

Researchers at Egypt’s Mansoura University have shown that mesenchymal stem cells hold promise in healing recalcitrant foot ulcers in patients with diabetes. In a study led by Ahmed Albehairy, MD, the scientists used a local injection of autologous bone-marrow-derived stem cells and found it greatly reduced ulcer size.

How Your Love Handles Could Help Someone With Diabetes

love handles stem cell treatment diabetes

Nature Communications reports that researchers at the Department of Biosystems Science and Engineering at ETH Zurich in Switzerland have succeeded in genetically reprogramming adipose stem cells into functional, insulin-producing beta cells. The team of biotechnologists, led by Professor Martin Fussenegger, extracted fat cells from a 50-year-old study subject and applied so-called “genetic software” to convert [Read More]

Get our newsletter for the latest news & updates.

Share the knowledge: